Literature DB >> 30207155

Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.

Katalin Barkovits1, Andreas Linden1, Sara Galozzi1, Lukas Schilde1, Sandra Pacharra1, Brit Mollenhauer2, Nadine Stoepel1, Simone Steinbach1, Caroline May1, Julian Uszkoreit1, Martin Eisenacher1, Katrin Marcus1.   

Abstract

Cerebrospinal fluid (CSF) is in direct contact with the brain and serves as a valuable specimen to examine diseases of the central nervous system through analyzing its components. These include the analysis of metabolites, cells as well as proteins. For identifying new suitable diagnostic protein biomarkers bottom-up data-dependent acquisition (DDA) mass spectrometry-based approaches are most popular. Drawbacks of this method are stochastic and irreproducible precursor ion selection. Recently, data-independent acquisition (DIA) emerged as an alternative method. It overcomes several limitations of DDA, since it combines the benefits of DDA and targeted methods like selected reaction monitoring (SRM). We established a DIA method for in-depth proteome analysis of CSF. For this, four spectral libraries were generated with samples from native CSF ( n = 5), CSF fractionation (15 in total) and substantia nigra fractionation (54 in total) and applied to three CSF DIA replicates. The DDA and DIA methods for CSF were conducted with the same nanoLC parameters using a 180 min gradient. Compared to a conventional DDA method, our DIA approach increased the number of identified protein groups from 648 identifications in DDA to 1574 in DIA using a comprehensive spectral library generated with DDA measurements from five native CSF and 54 substantia nigra fractions. We also could show that a sample specific spectral library generated from native CSF only increased the identification reproducibility from three DIA replicates to 90% (77% with a DDA method). Moreover, by utilizing a substantia nigra specific spectral library for CSF DIA, over 60 brain-originated proteins could be identified compared to only 11 with DDA. In conclusion, the here presented optimized DIA method substantially outperforms DDA and could develop into a powerful tool for biomarker discovery in CSF. Data are available via ProteomeXchange with the identifiers PXD010698, PXD010708, PXD010690, PXD010705, and PXD009624.

Entities:  

Keywords:  CSF; DIA; cerebrospinal fluid; data-independent acquisition mass spectrometry; proteomics; spectral library

Mesh:

Substances:

Year:  2018        PMID: 30207155     DOI: 10.1021/acs.jproteome.8b00308

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  Targeted Protein Quantification Using Parallel Reaction Monitoring (PRM).

Authors:  Katalin Barkovits; Weiqiang Chen; Michael Kohl; Thilo Bracht
Journal:  Methods Mol Biol       Date:  2021

2.  Progress on Identifying and Characterizing the Human Proteome: 2019 Metrics from the HUPO Human Proteome Project.

Authors:  Gilbert S Omenn; Lydie Lane; Christopher M Overall; Fernando J Corrales; Jochen M Schwenk; Young-Ki Paik; Jennifer E Van Eyk; Siqi Liu; Stephen Pennington; Michael P Snyder; Mark S Baker; Eric W Deutsch
Journal:  J Proteome Res       Date:  2019-09-13       Impact factor: 4.466

3.  The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia.

Authors:  Karin E Borgmann-Winter; Kai Wang; Sabyasachi Bandyopadhyay; Abolfazl Doostparast Torshizi; Ian A Blair; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2019-08-13       Impact factor: 4.662

4.  Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein.

Authors:  Katalin Barkovits; Niels Kruse; Andreas Linden; Lars Tönges; Kathy Pfeiffer; Brit Mollenhauer; Katrin Marcus
Journal:  Cells       Date:  2020-02-05       Impact factor: 6.600

5.  Reproducibility, Specificity and Accuracy of Relative Quantification Using Spectral Library-based Data-independent Acquisition.

Authors:  Katalin Barkovits; Sandra Pacharra; Kathy Pfeiffer; Simone Steinbach; Martin Eisenacher; Katrin Marcus; Julian Uszkoreit
Journal:  Mol Cell Proteomics       Date:  2019-11-07       Impact factor: 5.911

6.  Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease.

Authors:  Ozge Karayel; Sebastian Virreira Winter; Shalini Padmanabhan; Yuliya I Kuras; Duc Tung Vu; Idil Tuncali; Kalpana Merchant; Anne-Marie Wills; Clemens R Scherzer; Matthias Mann
Journal:  Cell Rep Med       Date:  2022-06-21

7.  Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease.

Authors:  Justin McKetney; Daniel J Panyard; Sterling C Johnson; Cynthia M Carlsson; Corinne D Engelman; Joshua J Coon
Journal:  Proteomics Clin Appl       Date:  2021-04-26       Impact factor: 3.494

8.  Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Diana A Abbasi; Thu T A Nguyen; Deborah A Hall; Erin Robertson-Dick; Elizabeth Berry-Kravis; Stephanie M Cologna
Journal:  Cerebellum       Date:  2021-05-27       Impact factor: 3.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.